UVX is a University of British Columbia (UBC)-affiliated company recognized as Canada's most impactful and investable healthcare startup by TELUS Pollinator Fund. UVX helps businesses reduce infection risk. We have developed an intelligent ceiling device that kills pathogens within seconds, both in the air and on surfaces, even when humans are present. The World Health Organization has acknowledged UVX's core technology as “the way forward" for disinfection for its ability to safely inactivate pathogens that cause COVID-19, Influenza, MRSA, E-Coli, Salmonella, and many other infections.